CellCarta, Imagene AI Broaden Ties on AI Biomarkers, Companion Diagnostics
Unite.AI
Read the full articleCellCarta and Imagene AI have expanded their partnership to jointly develop and scale AI-driven biomarker and companion diagnostic programs for biopharma, currently collaborating on projects with two global pharmaceutical firms. Their work integrates Imagene AI's assay development and biomarker prediction with CellCarta's diagnostic and regulatory expertise, including applications in immunohistochemistry and lung cancer biomarker prediction.




